LONDON BROKER RATINGS: Oddo BHF cuts Wizz Air and Ryanair
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More
| Price | 14,104.00p on 06-02-2026 at 19:40:05 |
|---|---|
| Change | 124.00p 0.89% |
| Buy | 14,084.00p |
| Sell | 14,080.00p |
| Last Trade: | Unknown 1.00 at 14,230.17236p |
| Day's Volume: | 3,108,416 |
| Last Close: | 14,104.00p |
| Open: | 13,884.00p |
| ISIN: | GB0009895292 |
| Day's Range | 13,846.00p - 14,112.00p |
| 52wk Range: | 9,574.00p - 14,408.00p |
| Market Capitalisation: | £218.65b |
| VWAP: | 13,952.70351p |
| Shares in Issue: | 1.55b |
Astrazeneca (AZN) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 1 | 14,230.17236p | Cross Currency Conversion OTC Trade |
19:02:31 - 06-Feb-26 |
| Unknown* | 0 | 14,146.08618p | SI Trade Currency Conversion |
19:02:17 - 06-Feb-26 |
| Unknown* | 0 | 14,146.08618p | SI Trade Currency Conversion |
19:02:17 - 06-Feb-26 |
| Unknown* | 0 | 14,146.08618p | SI Trade Currency Conversion |
19:02:17 - 06-Feb-26 |
| Unknown* | 0 | 14,146.08618p | SI Trade Currency Conversion |
19:02:17 - 06-Feb-26 |
| Unknown* | 0 | 14,146.08618p | SI Trade Currency Conversion |
19:02:17 - 06-Feb-26 |
| Unknown* | 2 | 14,224.9995p | Cross Currency Conversion OTC Trade |
19:01:11 - 06-Feb-26 |
| Unknown* | 0 | 14,120.21401p | SI Trade Currency Conversion |
18:45:10 - 06-Feb-26 |
| Unknown* | 0 | 14,220.57195p | SI Trade Currency Conversion |
18:45:06 - 06-Feb-26 |
| Unknown* | 0 | 14,265.58543p | SI Trade Currency Conversion |
18:13:49 - 06-Feb-26 |
Astrazeneca (AZN) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 3rd Feb 2026 7:00 am | RNS | Update on Saphnelo subcutaneous administration |
| 2nd Feb 2026 3:00 pm | RNS | Total Voting Rights |
| 2nd Feb 2026 7:05 am | RNS | Imfinzi recommended in EU for early gastric cancer |
| 2nd Feb 2026 7:00 am | RNS | AstraZeneca begins trading on NYSE |
| 30th Jan 2026 7:00 am | RNS | AstraZeneca agrees obesity and T2D deal with CSPC |
| 29th Jan 2026 9:51 am | RNS | AstraZeneca invests $15bn in China through 2030 |
| 20th Jan 2026 7:00 am | RNS | AstraZeneca to complete direct listing on NYSE |
| 8th Jan 2026 7:00 am | RNS | AZN new Head of Investor Relations Joris Silon |
| 2nd Jan 2026 3:00 pm | RNS | Total Voting Rights |
| 22nd Dec 2025 11:00 am | RNS | Director/PDMR Shareholding |